— Know what they know.
Not Investment Advice

CFOR OTC

CapForce Inc.
1W: +0.2% 1M: -21.4% 3M: -75.5% YTD: -83.6%
$4.05
+0.01 (+0.25%)
 
Weekly Expected Move ±19.3%
$2 $3 $4 $5 $6
OTC · Financial Services · Financial - Capital Markets · Tech Score Sell · Power 38 · $42.6M mcap · 4M float · 0.027% daily turnover · Short 23% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$42.6M
52W Range0.0001-34
Volume100
Avg Volume1,058
Beta0.00
Dividend—
Analyst Ratings
2 Buy 1 Hold 0 Sell
Consensus Buy
Company Info
CEOChristian-Laurent Benoit Bonte
Employees3
SectorFinancial Services
IndustryFinancial - Capital Markets
IPO Date2015-05-05
23219 Stringtown Road
Clarksburg, MD 20871
US
240 813 1260
About CapForce Inc.

CapForce Inc. is a precision medicine company dedicated to developing and commercializing sophisticated molecular microbiology solutions. Its mission is to address life-threatening infectious diseases for patients in the United States and across international markets. The company's diverse product range includes Unyvero application cartridges, Unyvero systems, Acuitas AMR Gene Panel diagnostic tests, and SARS CoV-2 testing kits. Beyond its product line, CapForce extends its offerings to include laboratory services, collaboration services (such as funded software arrangements), and licensing agreements. Additionally, the company provides listing sponsorship and consultancy services. Formerly known as OpGen, Inc., the entity officially changed its name to CapForce Inc. in February 2026. CapForce Inc. was established in 2001 and maintains its headquarters in Clarksburg, Maryland.

Latest News
No recent news

Recent Insider Trades

NameTypeSharesPriceDate
Azudin Mohd Azham A-Award 5,555 — 2026-02-23
Chua Kok Hoe Victor A-Award 5,555 — 2026-02-23
Low Yu Jie Ethan A-Award 5,555 — 2026-02-23
Wong Poh Yin Constan A-Award 5,555 — 2026-02-23
Bonte Christian-Laur 0 — 2025-12-01

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms